{{Rsnum
|rsid=9619311
|Gene=SYN3
|Chromosome=22
|position=32800707
|Orientation=plus
|GMAF=0.3356
|Gene_s=SYN3,TIMP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 44.2 | 48.7
| HCB | 1.5 | 14.6 | 83.9
| JPT | 0.9 | 17.7 | 81.4
| YRI | 40.1 | 47.6 | 12.2
| ASW | 21.1 | 64.9 | 14.0
| CHB | 1.5 | 14.6 | 83.9
| CHD | 0.0 | 19.3 | 80.7
| GIH | 5.9 | 41.6 | 52.5
| LWK | 59.1 | 30.9 | 10.0
| MEX | 12.1 | 46.6 | 41.4
| MKK | 36.5 | 43.6 | 19.9
| TSI | 19.6 | 37.3 | 43.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=23813847
|Title=The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a systematic review and meta-analysis
}}
{{PMID Auto
|PMID=23819551
|Title=Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility
}}

{{PMID Auto
|PMID=19431211
|Title=Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
|OA=1
}}

{{PMID Auto
|PMID=24903383
|Title=TIMP-3 -1296 T&gt;C and TIMP-4 -55 T&gt;C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women
}}

{{PMID Auto
|PMID=24913092
|Title=Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}